Logo Lucerna-Chem
+41 41 420 9636

Article Status


Trastuzumab deruxtecan


Catalog Number Pack Size List Price* Promo Price* Quantity
HY-138298-5MG 5 mg 1'320,00 1'122,00 Add

* CHF, excl. 7.7% VAT and shipping costs


Product Description

DS-8201; DS-8201a
Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, and a topoisomerase I inhibitor. Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer.

Category Biochemicals
Supplier MedChem Express
Application Cancer-Kinase/protease
Regulatory Status RUO
Grade Clinical information: No Development Reported
Purity 99.4%
CAS-Number [1826843-81-5]
Storage Conditions Pure form -20°C 3 years, 4°C 2 years; In solvent -80°C 6 months, -20°C 1 month
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support
tech@lucerna-chem.ch

Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

Newsletter













If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.


© Copyright 2021 Lucerna-Chem AG, Switzerland